Expertise at Chang Gung System

Chang, Yu-Liang , DDS.
Intitution:Linkou Chang Gung Memorial Hospital
Position: Attending Surgeon
Department: Oral and Maxillofacial Surgery
Address: No.5, Fusing St., Gueishan District, Taoyuan City 333, Taiwan (R.O.C.)
Tel: +886-3-3281200 ext. 8333 Fax: +886-3-3281200 ext. 8320
E-mail: ylchang@cgmh.org.tw

Focus of Interest:
  • Cancer Research
  • Dentistry, Oral Surgery & Medicine
  • Tissue Engineering

Fulltime Employment:
  • Assistant Professor, College of Dentistry, National Yang Ming University, Taipei, Taiwan
  • Attending Surgeon, Division of Oral & Maxillofacial Surgery, Taipei Chang Gung Memorial Hospital
  • Director, Division of Oral & Maxillofacial Surgery, Linkou Chang Gung Memorial Hospital

Education:
 》 DDS, College of Dentistry, National Yang Ming University, Taipei, Taiwan
 》 PhD, College of Dentistry, University of Iowa, USA

Selected Publications:
  1. Y. L. Chang, C. M. Stanford and J. C. Keller: Calcium and phosphate supplementation promotes bone cell mineralization – implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mat Res, 52:270-278, 2000. (Article Identifier: 10951365)
  2. Y. L. Chang, D. Lew, J. B. Park and J. C. Keller: Biomechanical and morphometric analysis of HA-coated implants with varying crystallinity. J Oral & Maxillofac Surg 57(9):1096-1108, 1999. ( Article Identifier: 10484111)
  3. Y. L. Chang, C. M. Stanford, J. S. Wefel and J. C. Keller: Osteoblastic cell attachment to hydroxyapatite-coated implant surfaces in vitro. Int J Oral & Maxillofac Implants 14(2):239-247, 1999. (Article Identifier: 10212541)
  4. Y. L. Chang: Hydroxyapatite(HA) coatings on titanium implants – the significance of crystallinity on in vitro and in vivo responses. PhD Thesis, Iowa City, IA, University of Iowa, July 1999.

Full Publication List

Board Certification:
  • Board-certified Diplomate, Taiwan Association of Oral and Maxillofacial Surgerons
  • Board-certified Diplomate, Academy of Oral Implantology R.O.C.

Ongoing Projects:
  1. Potential application of the regulation mechanism of activin A activation through EGFR CMRPG3F0151-3 2016/01/01-2018/12/31 Co-investigator
  2. In search of novel oral cancer biomarkers by low molecular weight proteomic strategy (MOST105-2628-B-182A-008-MY3) NMRPG3F6231 2016/08/01-2019/07/31 Co-investigator